Growth Metrics

Nexalin Technology (NXL) Equity Average (2021 - 2026)

Nexalin Technology has reported Equity Average over the past 5 years, most recently at $4.3 million for Q4 2025.

  • For Q4 2025, Equity Average fell 1.36% year-over-year to $4.3 million; the TTM value through Dec 2025 reached $4.3 million, down 1.36%, while the annual FY2025 figure was $3.7 million, 7.87% up from the prior year.
  • Equity Average for Q4 2025 was $4.3 million at Nexalin Technology, down from $5.4 million in the prior quarter.
  • Over five years, Equity Average peaked at $5.9 million in Q4 2022 and troughed at -$2.1 million in Q2 2022.
  • A 5-year average of $2.8 million and a median of $3.2 million in 2023 define the central range for Equity Average.
  • Biggest five-year swings in Equity Average: surged 424.18% in 2022 and later tumbled 57.86% in 2024.
  • Year by year, Equity Average stood at -$1.8 million in 2021, then surged by 424.18% to $5.9 million in 2022, then crashed by 45.55% to $3.2 million in 2023, then surged by 34.0% to $4.3 million in 2024, then dropped by 1.36% to $4.3 million in 2025.
  • Business Quant data shows Equity Average for NXL at $4.3 million in Q4 2025, $5.4 million in Q3 2025, and $4.1 million in Q2 2025.